Topic 1: Foundations in Opioid Use Disorder (OUD) and OUD Treatment

Understanding addiction is essential to successfully addressing it. By understanding the neurological responses to substances and brain changes that occur during addiction, participants will better be able to educate and treat patients with substance use disorder (SUD).  Substance Use Disorder (SUD) is often viewed as a moral failing and not as a medically treatable chronic...

Faculty

• Michelle R. Lofwall , MD, DFASAM

Overdose is the leading cause of accidental injury death in the United States surpassing motor vehicle crashes.  Opioids, prescribed for pain and used illicitly, are driving the increases in overdose deaths. Overdose prevention education and prescribing naloxone rescue kits to people at risk for opioid overdose is an emerging strategy to address opioid overdose.

Faculty

• Monica F. Roberts , PharmD

Opioid use disorder is a commonly encountered disorder with high levels of associated morbidity and mortality. Medications for Opioid Use Disorder (MOUD) are an effective but underutilized treatment that can save lives and improve quality of life for patients with OUD. Increasing patient access to these medications can lead to significant improvement in outcomes for patients with...

Faculty

• James D. Hawthorne III , MD

Opioid use disorder is a commonly encountered disorder with high levels of associated morbidity and mortality. Medications for Opioid Use Disorder (MOUD) are an effective but underutilized treatment that can save lives and improve quality of life for patients with OUD. Increasing patient access to these medications can lead to significant improvement in outcomes for patients with...

Faculty

• James D. Hawthorne III , MD

Less than 20% of individuals with an opioid use disorder (OUD) receive treatment including medications. Low-threshold medication for opioid use disorder (MOUD) treatment represent a key link between episodes of illness driven by opioid use disorder (OUD) and effective management of OUD.

Faculty

• Laura C. Fanucchi , MD, MPH

Less than 20% of individuals with an opioid use disorder (OUD) receive treatment including medications. Low-threshold medication for opioid use disorder (MOUD) treatment represent a key link between episodes of illness driven by opioid use disorder (OUD) and effective management of OUD.

Faculty

• Laura C. Fanucchi , MD, MPH

Motivational interviewing is a proven evidence-based approach to promote behavior change, but how it is best implemented and maintained in everyday clinical practice is often not clear. 

Faculty

• Devin A. Oller , MD, FACO, FASAM

Motivational interviewing is a proven evidence-based approached to promote behavior change, but how it is best implemented and maintained in an everyday clinical practice is often not clear.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Problematic substance use often goes unrecognized in primary care settings, either due to insufficient screening or provider discomfort with how to manage a positive screen. Understanding and implementing screening and assessment tools can help providers recognize problematic substance use.

Faculty

• Katrina Nickels , MD

Problematic substance use often goes unrecognized in primary care settings, either due to insufficient screening or provider discomfort with how to manage a positive screen. Understanding and implementing screening and assessment tools can help providers recognize problematic substance use.

Faculty

• Katrina Nickels , MD

Harm reduction practices can reduce the risk of illness or injury among people who use drugs. Formal settings such as healthcare, corrections, or recovery and treatment programs can be opportunities for conversations about harm reduction.

Faculty

• Alyssa M. Tremblay , MSW CSW
• Kayla Strother , APRN AGPCNP
• Angella Linder , BSN RN PMHBC

Harm reduction practices can reduce the risk of illness or injury among people who use drugs. Formal settings such as healthcare, corrections, or recovery and treatment programs can be opportunities for conversations about harm reduction.

Faculty

• Alyssa M. Tremblay , MSW CSW
• Kate Dunn , BSN, RN

Access to medications for opioid use disorder is limited in part due to minimal provider knowledge about treatment options, including extended-release naltrexone. Adequate understanding among providers and patients of the risks involved with extended release naltrexone contribute to lower rates of retention in care on this medication compared to other forms of MOUD. Significant...

Faculty

• Devin A. Oller , MD, FACO, FASAM

Access to medications for opioid use disorder is limited in part due to minimal provider knowledge about treatment options, including extended-release naltrexone. Adequate understanding among providers and patients of the risks involved with extended release naltrexone contribute to lower rates of retention in care on this medication compared to other forms of MOUD. Significant...

Faculty

• Devin A. Oller , MD, FACO, FASAM

Medications for Opioid Use Disorder (MOUD) are an effective but underutilized treatment that can save lives and improve quality of life for patients with OUD. Despite the evidence that MOUD save lives, behavioral interventions are often used alone in a treatment plan or as a requirement to gain access to MOUD. Understanding behavioral interventions in the treatment of OUD and as a...

Faculty

• Devin A. Oller , MD, FACO, FASAM
• Liza B. Bastin , MD

Medications for Opioid Use Disorder (MOUD) are an effective but underutilized treatment that can save lives and improve quality of life for patients with OUD. Despite the evidence that MOUD save lives, behavioral interventions are often used alone in a treatment plan or as a requirement to gain access to MOUD. Understanding behavioral interventions in the treatment of OUD and as a...

Faculty

• Laura C. Fanucchi , MD, MPH

The purpose of this training is to educate the participants about the Trauma-Informed Care Continuum and the pervasiveness of trauma in our communities, including the current opioid crisis and substance use disorder. Individuals who struggle with substance use disorder are at an increased risk for exposure to traumas, in addition to risk factors unique to their culture....

Faculty

• Kristal Hankinson , LMFT

Understanding addiction is essential to successfully addressing it. By understanding the neurological responses to substances and theories of addiction, participants will better be able to treat patients with SUD. Furthermore, substance Use Disorder (SUD) is often looked at as a moral failing and not as a medically treatable chronic illness.

Faculty

• Michelle R. Lofwall , MD, DFASAM

Language can be used intentionally or unintentionally to perpetuate stigma in a healthcare setting. Changing our language is a crucial component of reducing stigma to improve the lives and health of people who use drugs or alcohol and people with addiction. This module will address this need.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Language can be used intentionally or unintentionally to perpetuate stigma in a healthcare setting. Changing our language is a crucial component of reducing stigma to improve the lives and health of people who use drugs or alcohol and people with addiction. This module will address this need.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Individuals with substance use disorders often face barriers to seeking sustainable resources to improve their recovery capital.  Transition between care settings presents vulnerabilities to individuals with SUD who are seeking resources

Faculty

• Emily Sprouse , CSW
• McKenzie Clarke , LSW
• Linda G. Edwards , CADC

Individuals with substance use disorders often face barriers to seeking sustainable resources to improve their recovery capital.  Transition between care settings presents vulnerabilities to individuals with SUD who are seeking resources

Faculty

• Emily Sprouse , CSW
• McKenzie Clarke , LSW
• Linda G. Edwards , CADC

Overdose deaths per 100,000 people occur at a higher rate with the Black/Non-Hispanic and American Indian, Alaska Natives than with White/Non-Hispanic group.  Culturally responsive services are crucial to address disparities in access and perceived benefit for addiction treatment in marginalized communities

Faculty

• Fabiola Arbelo-Cruz , MD

Overdose deaths per 100,000 people occur at a higher rate with the Black/Non-Hispanic and American Indian, Alaska Natives than with White/Non-Hispanic group.  Culturally responsive services are crucial to address disparities in access and perceived benefit for addiction treatment in marginalized communities

Faculty

• Fabiola Arbelo-Cruz , MD

Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA), yet few patient care providers or patients are aware of what the protections are or how to file a case for an ADA violation. This talk will serve as a primer to explain how to...

Faculty

• Anna-Maria South , MD

Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA), yet few patient care providers or patients are aware of what the protections are or how to file a case for an ADA violation. This talk will serve as a primer to explain how to...

Faculty

• Anna-Maria South , MD

Individuals with OUD need more treatment options that can address problems such as: nonadherence, medication misuse/diversion/theft, access to care, and transportation limitations. Injectable m Michelle R. Lofwall , MD, DFASAM

Faculty

• Rachel V. Smith , MPH, CPH